Clear market notes built around the JSE, the rand, and what matters locally.

2026-10-03 00:30 • The Motley Fool Positive Axe Cap view: Selective

AMD stock surged 30% in September driven by strong CPU demand following Meta's launch of its Muse AI agent, which became the most downloaded app within a month. AMD also announced an $8.2 billion acquisition of World Labs to strengthen its AI hardware and software capabilities. Wall Street analysts upgraded the stock citing increased AI compute demand and CPU market expansion.

Axe note: AMD’s 30% jump in September highlights rising AI demand, with implications for rand and local tech exposure.

2026-10-03 00:13 • The Motley Fool Positive Axe Cap view: Selective

VanEck Pharmaceutical ETF (PPH) offers lower costs (0.36% expense ratio) and higher dividend yield (2%), making it better for long-term buy-and-hold investors. Invesco Pharmaceuticals ETF (PJP) delivered stronger 1-year returns (41% vs 31%) with more balanced U.S.-focused holdings, but charges higher fees (0.58%) and offers lower yield (0.9%).

Axe note: VanEck's PPH offers a lower-cost, higher-yield alternative to Invesco's PJP, better aligned with long-term income goals in rand terms.

2026-10-02 23:25 • The Motley Fool Positive Axe Cap view: Selective

IDT stock surged 17% this week following strong Q4 fiscal 2026 earnings results and an analyst price target raise. The company reported 7% year-over-year revenue growth to $339 million and 29% growth in net income, though it slightly missed adjusted earnings expectations. Analyst Mikhail Paramonov raised his price target from $75 to $85 per share, citing confidence in the company's double-digit gross profit growth guidance for fiscal 2027.

Axe note: IDT's solid Q4 earnings and upbeat forecast lifted its stock by 17%, driven by fintech and telecom strength.